MEI Pharma and BeiGene Announce Clinical Collaboration to Evaluate ME-401 in Combination with Zanubrutinib in Patients with B-Cell Malignancies Life Science
Tilray joins in cash grab with $400 million debt sale as cannabis firms capitalize on euphoria Cannabis, Life Science
Cellular Bio Acquires Rights to Solid Tumor Immunotherapy from National Cancer Institute Life Science
Kite and HiFiBiO Therapeutics Announce a Research Collaboration to Develop Technology for the Potential Discovery of Neoantigen-Reactive T Cell Receptors (TCRs) for the Treatment of Cancer Life Science
Five Prime Therapeutics and Zai Lab Dosed First Patient in Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers Life Science